Ignite Creation Date:
2024-05-06 @ 1:48 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04123795
Status:
RECRUITING
Last Update Posted:
2024-03-29
First Post:
2019-10-09
Brief Title:
A Study to Evaluate the Efficacy Safety and Drug Concentration of Certolizumab Pegol CZP in Children and Adolescent Study Participants With Moderate to Severe Chronic Plaque Psoriasis PSO
Sponsor:
UCB Biopharma SRL
Organization:
UCB Pharma
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-21
Start Date Type:
ACTUAL
Primary Completion Date:
2029-09-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-08-14
Completion Date Type:
ESTIMATED
First Submit Date:
2019-10-09
First Submit QC Date:
October 9 2019
Study First Post Date:
2019-10-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-29
Last Update Post Date:
2024-03-29
Last Update Post Date Type:
ACTUAL